Ribocil-C is a highly selective inhibitor of bacterial flavin mononucleotide (FMN) riboswitches, used to suppress de novo riboflavin (vitamin B2) biosynthesis and uptake in bacteria such as Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii; it functions as a synthetic small-molecule mimic of FMN, binding to FMN riboswitches to inhibit ribB expression, riboflavin synthesis, and bacterial growth; in vivo, it demonstrates dose-dependent reduction of bacterial burden in infected mice without significant toxicity.